Vivo Capital — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.
BiotechHealthtechMedical DevicesNorthbrook, US
Jeffrey Aronin(Director)Jeffrey M. Dayno, M.D.(President and Chief Executive Officer)Patrick Morris(Secretary and Treasurer)Robert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)
BoardAaron Royston(Director)in
Board seatJack Nielsen· per SEC Form D · $50M raise · filed Aug 2019
Co-investorsAisling CapitalParagon Biosciences LLCValor Equity PartnersvenBio Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.